P2483Differential effects of novel antidiabetics on arterial stiffness in patients with type 2 diabetes mellitus
Evanthia Bletsa(National and Kapodistrian University of Athens), Dimitris Tousoulis(National and Kapodistrian University of Athens), Alexios S. Antonopoulos(National and Kapodistrian University of Athens), Nikolaοs Tentolouris, Zoi Pallantza(Hippocration General Hospital), Eva Kassi(Laiko General Hospital of Athens), Anastasia Thanopoulou(National and Kapodistrian University of Athens), Gerasimos Siasos(Brigham and Women's Hospital), Andromachi Vryonidou, Stavroula Α. Paschou(Beth Israel Deaconess Medical Center), Nikolaos Gouliopoulos(National and Kapodistrian University of Athens), Panagiota K. Stampouloglou(National and Kapodistrian University of Athens), Evangelos Oikonomou(National and Kapodistrian University of Athens), Konstantinos Batzias(National and Kapodistrian University of Athens), Vasiliki Tsigkou(National and Kapodistrian University of Athens)
Cited by 0
Related Papers
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-Year Follow-Up Outcomes and Differences Across Regions
|European Journal of Heart Failure|2016|781
A novel machine learning-derived radiotranscriptomic signature of perivascular fat improves cardiac risk prediction using coronary CT angiography
|European Heart Journal|2019|503
Prevention of Type 2 Diabetes by Lifestyle Changes: A Systematic Review and Meta-Analysis
|Nutrients|2019|475
Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
|International Journal of Molecular Sciences|2021|294